These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16231369)

  • 21. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
    Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
    Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer.
    Ewald J; Rodrigue CM; Mourra N; Lefèvre JH; Fléjou JF; Tiret E; Gespach C; Parc YR
    Br J Surg; 2007 Aug; 94(8):1020-7. PubMed ID: 17440950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma.
    Yamauchi T; Fujishima F; Tsunokake J; Kunimitsu A; Akaishi R; Ozawa Y; Fukutomi T; Okamoto H; Sato C; Taniyama Y; Kamei T; Ichinohasama R; Sasano H
    Int J Biol Markers; 2023 Jun; 38(2):105-113. PubMed ID: 37009661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
    Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
    Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
    Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
    Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
    Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical detection of hMLH1 and hMSH2 proteins in vulvar carcinoma.
    Kwasniewska A; Postawski K; Gozdzicka-Józefiak A; Zdunek M; Korobowicz E; Miturski R
    Int J Mol Med; 2005 Jun; 15(6):955-61. PubMed ID: 15870899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
    Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
    Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
    Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
    Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer.
    Kassem HS; Varley JM; Hamam SM; Margison GP
    Br J Cancer; 2001 Feb; 84(3):321-8. PubMed ID: 11161395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of MLH1 and microsatellite instability in esophageal squamous cell carcinomas.
    Liu FX; Huang XP; Xu X; Cai Y; Han YL; Wu RL; Wu M; Zhan QM; Wang MR
    Yi Chuan Xue Bao; 2005 Mar; 32(3):234-42. PubMed ID: 15931783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
    Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
    Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
    Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB
    Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of mismatch repair proteins MLH1, MSH2 and MSH6 correlates with the Ki67 proliferation index and survival in patients with recurrent glioblastoma.
    Stark AM; Doukas A; Hugo HH; Mehdorn HM
    Neurol Res; 2010 Oct; 32(8):816-20. PubMed ID: 20223108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.
    Shinto E; Baker K; Tsuda H; Mochizuki H; Ueno H; Matsubara O; Foulkes WD; Jass JR
    Dis Colon Rectum; 2006 Aug; 49(8):1193-202. PubMed ID: 16773493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
    Balmaña J; Stockwell DH; Steyerberg EW; Stoffel EM; Deffenbaugh AM; Reid JE; Ward B; Scholl T; Hendrickson B; Tazelaar J; Burbidge LA; Syngal S
    JAMA; 2006 Sep; 296(12):1469-78. PubMed ID: 17003395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
    Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
    Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.